Peter Fasching. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antirheumatic Agents/therapeutic useBiological Products/therapeutic useCombined Modality TherapyHLA-B27 Antigen/geneticsHumansInterleukin-1/antagonists & inhibitorsPhysical Therapy ModalitiesRheumatoid Factor/bloodSpondylarthritis/bloodSpondylarthritis/diagnosisSpondylarthritis/geneticsSpondylarthritis/rehabilitationTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antirheumatic AgentsBiological ProductsHLA-B27 AntigenInterleukin-1Tumor Necrosis Factor-alphaRheumatoid Factor
Year: 2010 PMID: 20632146 DOI: 10.1007/s10354-010-0792-3
Source DB: PubMed Journal: Wien Med Wochenschr ISSN: 0043-5341